Search
Search
Proteintech
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Immunogen sequence: MALRICVTY TPALPIGLCT RCCLCLEQSP SWCHCLRGVS FLTFHLHQSV PLGDRDSLLM FTRQAGHFVE GSKAGRSRGR LCLSQALRVA VRGAFVSLWF AAGAGDRERN KGDKGAQTGA GLSQEAEDVD VSRARRVTDA PQGTLCGTGN RNSGSQSARA VGVAHLGEAF RVGVEQAISS CPEEVHGRHG LSMEIMWARM DVALRSPGRG LLAGAGALCV TLAESSCPDY ERGRRACLTL HRHPTPHCST WGLPLRVAGS WLTVVTVEAL GGWRMGVRRT GQVGPTMHPP PVSGASPLLL HHLLLLLLII ILTC (1-313 aa encoded by BC011815)
MYEOV, also named as OCIM, was originally isolated by the application of the NIH/3T3 tumorigenicity assay with DNA from a gastric carcinoma. It is a prognostic factor for patients with multiple myeloma, in part through a role of MYEOV in the control of MMC proliferation. MYEOV is a candidate oncogene activated in the amplification core located proximal toCCND1.
仅用于科研。不用于诊断过程。未经明确授权不得转售。
蛋白别名: myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas); myeloma overexpressed gene (in a subset of t(11;14) positive multiple myelomas); Myeloma-overexpressed gene protein; Oncogene in multiple myeloma
基因别名: MYEOV; OCIM
UniProt ID: (Human) Q96EZ4
Entrez Gene ID: (Human) 26579